213 related articles for article (PubMed ID: 21968254)
1. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.
Todd CA; Greene KM; Yu X; Ozaki DA; Gao H; Huang Y; Wang M; Li G; Brown R; Wood B; D'Souza MP; Gilbert P; Montefiori DC; Sarzotti-Kelsoe M
J Immunol Methods; 2012 Jan; 375(1-2):57-67. PubMed ID: 21968254
[TBL] [Abstract][Full Text] [Related]
2. International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.
Ozaki DA; Gao H; Todd CA; Greene KM; Montefiori DC; Sarzotti-Kelsoe M
PLoS One; 2012; 7(1):e30963. PubMed ID: 22303476
[TBL] [Abstract][Full Text] [Related]
3. Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China.
Nie J; Wang W; Wen Z; Song A; Hong K; Lu S; Zhong P; Xu J; Kong W; Li J; Shang H; Ling H; Ruan L; Wang Y
J Virol Methods; 2012 Nov; 185(2):267-75. PubMed ID: 22796285
[TBL] [Abstract][Full Text] [Related]
4. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
Sarzotti-Kelsoe M; Bailer RT; Turk E; Lin CL; Bilska M; Greene KM; Gao H; Todd CA; Ozaki DA; Seaman MS; Mascola JR; Montefiori DC
J Immunol Methods; 2014 Jul; 409():131-46. PubMed ID: 24291345
[TBL] [Abstract][Full Text] [Related]
5. Measuring HIV neutralization in a luciferase reporter gene assay.
Montefiori DC
Methods Mol Biol; 2009; 485():395-405. PubMed ID: 19020839
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells.
Chen Q; Nie J; Huang W; Jiao Y; Li L; Zhang T; Zhao J; Wu H; Wang Y
Hum Vaccin Immunother; 2018 Jan; 14(1):199-208. PubMed ID: 28933644
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
Todd CA; Sanchez AM; Garcia A; Denny TN; Sarzotti-Kelsoe M
J Immunol Methods; 2014 Jul; 409():91-8. PubMed ID: 24120573
[TBL] [Abstract][Full Text] [Related]
8. Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.
Sarzotti-Kelsoe M; Daniell X; Todd CA; Bilska M; Martelli A; LaBranche C; Perez LG; Ochsenbauer C; Kappes JC; Rountree W; Denny TN; Montefiori DC
J Immunol Methods; 2014 Jul; 409():147-60. PubMed ID: 24607608
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
Polonis VR; Brown BK; Rosa Borges A; Zolla-Pazner S; Dimitrov DS; Zhang MY; Barnett SW; Ruprecht RM; Scarlatti G; Fenyö EM; Montefiori DC; McCutchan FE; Michael NL
Virology; 2008 Jun; 375(2):315-20. PubMed ID: 18367229
[TBL] [Abstract][Full Text] [Related]
10. Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.
Sanchez AM; Denny TN; O'Gorman M
J Immunol Methods; 2014 Jul; 409():1-5. PubMed ID: 24910413
[TBL] [Abstract][Full Text] [Related]
11. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
Lynch HE; Sanchez AM; D'Souza MP; Rountree W; Denny TN; Kalos M; Sempowski GD
J Immunol Methods; 2014 Jul; 409():62-71. PubMed ID: 24801479
[TBL] [Abstract][Full Text] [Related]
12. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP;
PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218
[TBL] [Abstract][Full Text] [Related]
13. Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
Hraber P; Rademeyer C; Williamson C; Seaman MS; Gottardo R; Tang H; Greene K; Gao H; LaBranche C; Mascola JR; Morris L; Montefiori DC; Korber B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747500
[TBL] [Abstract][Full Text] [Related]
14. Development of a proficiency testing program for the HIV-1 BED incidence assay in China.
Yan H; Yu H; Xing W; Xiao Y; Zhang H; Pei L; Zhang N; Jiang Y
Sci Rep; 2014 Mar; 4():4512. PubMed ID: 24676229
[TBL] [Abstract][Full Text] [Related]
15. Short communication: neutralizing antibodies in HIV-1-infected Brazilian individuals.
Almeida DV; Morgado MG; Côrtes FH; Guimarães ML; Mendonça-Lima L; Pilotto JH; Grinsztejn B; Veloso VG; Bongertz V
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):488-92. PubMed ID: 23145941
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
[TBL] [Abstract][Full Text] [Related]
17. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.
Ducar C; Smith D; Pinzon C; Stirewalt M; Cooper C; McElrath MJ; Hural J;
J Immunol Methods; 2014 Jul; 409():9-20. PubMed ID: 24709391
[TBL] [Abstract][Full Text] [Related]
18. Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?
van Gils MJ; Schuitemaker H
Curr HIV Res; 2010 Dec; 8(8):579-86. PubMed ID: 21054254
[TBL] [Abstract][Full Text] [Related]
19. International network for comparison of HIV neutralization assays: the NeutNet report II.
Heyndrickx L; Heath A; Sheik-Khalil E; Alcami J; Bongertz V; Jansson M; Malnati M; Montefiori D; Moog C; Morris L; Osmanov S; Polonis V; Ramaswamy M; Sattentau Q; Tolazzi M; Schuitemaker H; Willems B; Wrin T; Fenyö EM; Scarlatti G
PLoS One; 2012; 7(5):e36438. PubMed ID: 22590544
[TBL] [Abstract][Full Text] [Related]
20. Impact of host cell variation on the neutralization of HIV-1 in vitro.
Polonis VR; Schuitemaker H; Bunnik EM; Brown BK; Scarlatti G
Curr Opin HIV AIDS; 2009 Sep; 4(5):400-7. PubMed ID: 20048704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
